EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Reporting of D-dimer testing in venous thromboembolism diagnostic management studies: a scoping review

Robin V Hofstetter, Caterina E Marx, Noémie Kraaijpoel, Emmanuel J Favaloro, Patrick M Bossuyt, Piet Meijer, Steve Kitchen, Kerstin de Wit, Helia Robert-Ebadi, Grégoire Le Gal, Drahomir Aujesky, Rita Selby und 1 weitere

Journal of Thrombosis and Haemostasis · 2026-06 · 24 (6) · 2213-2221

DOI: 10.1016/j.jtha.2026.03.005 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-06. Verfasst von Robin V Hofstetter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: robin.hofs…. Hauptthemen laut MEDLINE: Fibrin Fibrinogen Degradation Products, Venous Thromboembolism, Pulmonary Embolism, Venous Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ottawa, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: D-dimer testing is widely integrated into diagnostic algorithms for venous thromboembolism (VTE). However, the lack of standardization across D-dimer assays and reporting may limit the comparability of study findings. OBJECTIVES: To summarize reporting of essential characteristics of D-dimer testing in VTE diagnostic management studies. METHODS: We systematically searched MEDLINE and Embase from January 1999 to August 2024 for VTE diagnostic management studies that evaluated diagnostic algorithms, including D-dimer testing, and followed patients for ≥ 4 weeks after VTE was excluded. The primary outcome was reporting of D-dimer assay characteristics. Secondary outcomes were reporting of patient numbers and failure rates per assay. RESULTS: Of 9670 articles screened, 58 studies were included: 36 (62%) enrolled patients with suspected pulmonary embolism, 21 (36%) with suspected deep vein thrombosis, and 1 with suspected VTE. Sample sizes ranged from 191 to 5400; follow-up was 1 to 6 months. Assay name was fully reported in 52 of 58 studies (90%), manufacturer in 49 of 58 (85%), unit magnitude in 42 of 46 (91%), and the unit type in 8/46 (17%). The detection limit was reported in 3 of 58 studies (5.2%); other analytical performance parameters were unreported. Nineteen quantitative assays were used across 19 combinations of thresholds and unit magnitudes. Of 17 studies using multiple assays, 9 reported patient numbers per assay, and 1 reported failure rate per assay. CONCLUSION: Key characteristics of D-dimer testing were inconsistently reported in VTE diagnostic management studies. While assay name, manufacturer, unit magnitude, and thresholds were often included, unit type and assay-specific data were frequently omitted. Minimum reporting standards for D-dimer testing are needed for VTE diagnostic management studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrin Fibrinogen Degradation ProductsVenous ThromboembolismPulmonary EmbolismVenous ThrombosisHumansBiomarkersPredictive Value of TestsAlgorithms

Stichwörter der Autor:innen

D-dimerdiagnosispulmonary embolismvenous thromboembolism

Substanzen

Fibrin Fibrinogen Degradation Productsfibrin fragment DBiomarkers

Autor:innen und Institutionen

  • Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: robin.hofstetter@insel.ch.
  • Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, C…
  • Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Department of Haematology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia.
  • Department of Epidemiology & Data Science, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
  • External Quality Control of Diagnostic Assays and Tests Foundation, Voorschoten, the Netherlands.

Förderung

  • University of Ottawa
  • Canadian Institutes of Health Research

Zitieren

APA

Hofstetter, R. V., Marx, C. E., Kraaijpoel, N., Favaloro, E. J., Bossuyt, P. M., Meijer, P., Kitchen, S., de Wit, K., Robert-Ebadi, H., Le Gal, G., Aujesky, D., Selby, R., & Tritschler, T. (2026). Reporting of D-dimer testing in venous thromboembolism diagnostic management studies: a scoping review. Journal of Thrombosis and Haemostasis, 24(6), 2213-2221. https://doi.org/10.1016/j.jtha.2026.03.005

Vancouver

Hofstetter RV, Marx CE, Kraaijpoel N, Favaloro EJ, Bossuyt PM, Meijer P, et al. Reporting of D-dimer testing in venous thromboembolism diagnostic management studies: a scoping review. Journal of Thrombosis and Haemostasis. 2026;24(6):2213-2221. doi:10.1016/j.jtha.2026.03.005

BibTeX
@article{Hofstetter2026,
  author = {Hofstetter, Robin V and Marx, Caterina E and Kraaijpoel, Noémie and Favaloro, Emmanuel J and Bossuyt, Patrick M and Meijer, Piet and Kitchen, Steve and de Wit, Kerstin and Robert-Ebadi, Helia and Le Gal, Grégoire and Aujesky, Drahomir and Selby, Rita and Tritschler, Tobias},
  title = {Reporting of D-dimer testing in venous thromboembolism diagnostic management studies: a scoping review},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {2213--2221},
  doi = {10.1016/j.jtha.2026.03.005}
}
Kostenlos starten →